Most people on Ozempic lose roughly 1 to 2 pounds per week on average, though the rate varies significantly depending on dose, starting weight, and how far along you are in treatment. In clinical trials, participants lost about 2% of their body weight in the first four weeks and around 15 to 17% of their starting weight after a full year.
Those weekly averages can be misleading, though, because weight loss on Ozempic isn’t steady. It starts slowly, accelerates as your dose increases, and eventually levels off. Here’s what that timeline actually looks like.
What to Expect in the First Month
The first four weeks are a titration period, meaning you start on the lowest dose (0.25 mg) to let your body adjust. Weight loss during this phase is modest. Clinical trials show participants lost about 2% of their body weight in the first four weeks when combining the medication with diet and exercise. For someone starting at 220 pounds, that’s roughly 4 to 5 pounds total, or about a pound per week.
Don’t expect dramatic results during this initial stretch. The low starting dose is designed to minimize side effects like nausea, not to maximize weight loss. The real changes come later.
Months 1 Through 6: When Loss Accelerates
As your dose increases from 0.25 mg to 0.5 mg and eventually to 1.0 mg or 2.0 mg, weight loss picks up. In the STEP 1 trial (which tested the higher-dose version of semaglutide at 2.4 mg), participants had lost an average of 9.6% of their body weight by three months and 13.8% by six months. That works out to roughly 1.5 to 2 pounds per week during the most active weight loss phase for someone who started around 230 pounds.
Ozempic’s approved doses top out at 2.0 mg, which is lower than the 2.4 mg dose used in those trials (that higher dose is marketed as Wegovy). So results on Ozempic specifically tend to be somewhat more modest. In the SUSTAIN FORTE trial comparing Ozempic’s two highest doses, participants on 2.0 mg lost about 15.2 pounds over 40 weeks, while those on 1.0 mg lost about 13.2 pounds. That translates to roughly 0.3 to 0.4 pounds per week, though these participants had type 2 diabetes, which typically slows weight loss compared to people using semaglutide for weight management alone.
How Dose Affects Your Results
Higher doses produce more weight loss, but the difference between doses isn’t as large as you might think. In the SUSTAIN FORTE trial, the jump from 1.0 mg to 2.0 mg added only about 2 extra pounds of weight loss over 40 weeks. The biggest leap happens when moving from the starter doses (0.25 mg and 0.5 mg) up to the therapeutic range.
People with type 2 diabetes consistently lose less weight on semaglutide than those without it. In one trial, participants with obesity and diabetes lost an average of 10.4% of their body weight on the 2.4 mg dose, compared to the 15 to 17% seen in trials of people without diabetes. Insulin resistance and related metabolic factors slow the process down. A newer, higher dose of 7.2 mg pushed weight loss in people with diabetes to 13.2%, narrowing that gap.
Why Weight Loss Slows and Plateaus
Weight loss on semaglutide doesn’t continue at the same rate forever. Most people plateau around 60 weeks (roughly 14 months). At that point, the rate drops to near zero, and your weight stabilizes at its new lower level. This isn’t a failure of the medication. It reflects your body reaching a new equilibrium where the calorie deficit created by reduced appetite and slower digestion is matched by your lower metabolic needs.
Plateaus can also happen earlier, particularly when transitioning between doses or if your body adapts to the appetite-suppressing effects. The medication works by activating receptors in the brain that control hunger and fullness, while also slowing how quickly food leaves your stomach. Both effects reduce how much you eat without requiring constant willpower, but your body does partially adapt over time.
Fat Loss vs. Muscle Loss
One important detail that weekly weigh-ins won’t tell you: not all the weight you lose is fat. In the STEP 1 trial, participants lost an average of 33.7 pounds, but about 15.2 of those pounds came from lean mass (muscle and other non-fat tissue). That means roughly 45% of the total weight lost was lean mass, which is significantly higher than the general rule of thumb that about 25% of weight loss comes from lean tissue.
This matters because losing muscle lowers your resting metabolism and can affect strength, bone health, and physical function. Resistance training and adequate protein intake during treatment can help preserve muscle, and many clinicians now recommend both as standard practice alongside semaglutide.
Realistic Weekly Numbers by Phase
- Weeks 1 to 4 (0.25 mg): About 0.5 to 1 pound per week. Minimal appetite changes for some people.
- Months 2 to 3 (0.5 mg): Around 1 to 1.5 pounds per week as appetite suppression becomes more noticeable.
- Months 3 to 6 (1.0 to 2.0 mg): Peak weight loss phase, averaging 1.5 to 2 pounds per week for many people.
- Months 6 to 12: The rate gradually slows to under 1 pound per week as you approach your plateau.
- Beyond 12 to 14 months: Weight stabilizes. Continued use maintains the loss rather than producing further drops.
These numbers assume consistent use alongside diet and exercise. Individual results vary widely. Some people lose significantly more, others less. Starting weight, metabolic health, diabetes status, age, and how closely you follow lifestyle changes all play a role. The weekly average also looks different depending on whether you’re on Ozempic’s maximum dose of 2.0 mg or the higher 2.4 mg semaglutide dose available as Wegovy.